Cha AI Healthkare Co Ltd

Cha AI Healthkare Co Ltd has a debt-to-equity ratio of 0.41 and a current ratio of 1.49, indicating a moderate level of liquidity and a relatively balanced capital structure. However, the company's operating cash flow is negative at -6,711,883,380 KRW, and its net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability metrics are mixed. It reports a return on equity (ROE) of 1.81% and a return on assets (ROA) of 1.24%, both below the typical thresholds for strong performance in the personal care products industry. The net income of 1,366,856,610 KRW contrasts with a significant operating loss of -7,456,013,890 KRW, highlighting operational inefficiencies or cost overruns. Cha AI Healthkare Co Ltd's revenue is derived from cosmetics and medical devices, with distribution through home shopping, internet shopping malls, mail-order sale, and other channels. The company does not disclose segment-specific revenue figures, but its product portfolio includes black water glow masks, intensive shining masks, and eye gel patches. Geographically, the company is concentrated in Korea, with no disclosed international revenue streams. The company's growth trajectory is uncertain. While it has a free cash flow of 1,502,057,300 KRW, the operating cash flow is negative, and the operating income is significantly negative. The outlook for the current fiscal year and the next fiscal year is not explicitly provided, but the financial snapshot suggests a challenging operating environment. The risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The dilution risk is low, and no specific dilution sources are identified in the provided data. The company's capital structure and financial performance suggest a need for careful monitoring of liquidity and operational efficiency. Recent events and filings for Cha AI Healthkare Co Ltd are not detailed in the provided data. The analyst estimate for the last actual EPS is -45,785.92, indicating a significant loss per share. The company's financial performance and operational results suggest a need for further analysis of its strategic direction and cost management.